Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 22 | 2 | 2 |
| Receivables | 95 | 93 | 92 | 110 | 109 |
| TOTAL | $95 | $94 | $114 | $112 | $111 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $95 | $94 | $114 | $112 | $111 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 91 | 67 | 64 | 61 | 60 |
| Accrued Expenses | 0 | 31 | 48 | 48 | 0 |
| TOTAL | $91 | $98 | $112 | $109 | $60 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $91 | $98 | $112 | $109 | $60 |
| Shareholders' Equity | |||||
| Common Shares | 316 | 316 | 316 | 316 | 316 |
| Retained earnings | -402 | -410 | -404 | -402 | -355 |
| Other shareholders' equity | 90 | 90 | 90 | 90 | 90 |
| TOTAL | $4 | $-4 | $1 | $3 | $51 |
| Total Liabilities And Equity | $95 | $94 | $114 | $112 | $111 |